McKESSON CORPORATION last reported quarterly results on Nov 4, 2026, for Q2 FY2027 (the quarter ended Sep 30, 2026): revenue of $111.0 billion (+7.6% year over year) and diluted EPS of $10.44. It usually reports 35–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 3, 2027.
Results for Q3 FY2027, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 4, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 35–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q2 FY2027
ended Sep 30, 2026
|
110,957
+7.6%
|
1,218
+9.7%
|
10.44
+17.0%
|
|
Aug 5, 2026
36 days after quarter end
|
Q1 FY2027
ended Jun 30, 2026
|
105,380
+7.7%
|
614
-21.7%
|
5.15
-17.6%
|
|
May 7, 2026
37 days after quarter end
|
Q4 FY2026
ended Mar 31, 2026
|
96,295
+6.0%
|
1,682
+33.5%
|
13.69
+36.8%
|
|
Feb 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Dec 31, 2025
|
106,158
+11.4%
|
1,186
+34.9%
|
9.59
+38.0%
|
|
Nov 5, 2025
36 days after quarter end
|
Q2 FY2026
ended Sep 30, 2025
|
103,150
+10.1%
|
1,110
+360.6%
|
8.92
+377.0%
|
|
Aug 6, 2025
37 days after quarter end
|
Q1 FY2026
ended Jun 30, 2025
|
97,827
+23.4%
|
784
-14.3%
|
6.25
-10.7%
|
|
May 8, 2025
38 days after quarter end
|
Q4 FY2025
ended Mar 31, 2025
|
90,823
+18.9%
|
1,260
+59.3%
|
10.00
+66.5%
|
|
Feb 5, 2025
36 days after quarter end
|
Q3 FY2025
ended Dec 31, 2024
|
95,294
+17.8%
|
879
+49.2%
|
6.95
+57.2%
|
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- MCK (NYSE)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Irving, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 927653
- Former names
- MCKESSON HBOC INC (until Aug 13, 2001)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.